查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1684318

藥物整合聚合物纖維市場，按類型、按應用、按治療適應症、按最終用戶、按國家和地區 - 2025 年至 2032 年全球行業分析、市場規模、市場佔有率和預測

Drug Integrated Polymer Fibers Market, By Type, By Application, By Therapeutic Indication, By End-User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 301 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告重點

2024 年藥物整合聚合物纖維市場價值為 8,598 萬美元，2025 年至 2032 年期間複合年成長率為 5.90%。

藥物整合聚合物纖維市場-市場動態

個人化醫療需求的不斷成長預計將推動市場成長。

個人化醫療透過針對個別患者的針對性治療徹底改變了藥物傳遞方式，進而促進了基於聚合物的藥物輸送系統的使用。含有藥物的聚合物纖維能夠控制並持續釋放藥物，從而確保根據每位患者的獨特需求最佳化治療效果。 2023年，FDA批准了16種針對罕見疾病患者的新型個人化治療方法，較2022年的6種核准有大幅增加。儘管如此，纖維製造技術的進步可能為市場帶來成長機會。相反，高昂的製造成本可能會阻礙市場擴張。

藥物整合聚合物纖維市場-關鍵見解

根據我們的研究分析師的分析，預測期內（2025-2032 年），全球市場預計年複合成長率約為 5.90%

根據類型細分，預計聚乳酸 (PLA) 將在 2024 年佔據最大市場佔有率

根據應用細分，骨科縫合線是 2024 年的主要應用

從地區來看，北美是 2024 年的主要收入來源

藥物整合聚合物纖維市場-細分分析：

全球藥物整合聚合物纖維市場根據類型、應用、治療指徵、最終用戶和地區進行細分。

根據類型，市場分為三類：聚乳酸 (PLA)、聚二氧化酮 (PDO)、聚己內酯 (PCL) 和其他 (PGA、PLGA 和 PDLL)。聚乳酸（PLA）引領市場。聚乳酸 (PLA) 是一種可生物分解且生物相容性的聚合物，由於其可加工成纖維、薄膜和其他形式以控制藥物釋放，因此經常用於該市場。 PLA 源自玉米澱粉或甘蔗等可再生資源，是一種環保選擇。它的生物分解性使得纖維在體內逐漸分解，從而最大限度地減少了手術切除的需要。

根據應用，市場分為五類：藥物傳遞、骨科縫合線、血管支架、血管移植、皮膚傷口癒合等。骨科縫合線佔據市場主導地位。骨科縫合線中的藥物整合聚合物纖維市場代表​​了醫療器材產業中一個前景光明且快速發展的領域，它結合了聚合物纖維的生物相容性與骨科應用中有效和局部藥物傳遞的需求。由藥物整合聚合物纖維製成的骨科縫合線旨在透過將藥物直接輸送到手術部位來促進癒合。這在骨科手術中尤其重要，因為骨骼和軟組織的正確癒合對於長期復原至關重要。

根據治療適應症，市場分為三類：癌症、心血管疾病和呼吸系統疾病。隨著技術的進步，這些纖維將變得更加複雜，可以更好地控制藥物釋放和個人化的治療方法，最終改善患者的治療效果和生活品質。在這些治療領域使用聚合物纖維進行藥物傳遞的最顯著優勢之一是能夠提供局部和有針對性的治療，最大限度地減少全身副作用。藥物整合聚合物纖維的開發必須滿足嚴格的監管要求，特別是在生物相容性、安全性和長期療效方面。

根據最終用戶，市場分為兩類：製藥公司和醫療器材製造商。藥物整合聚合物纖維市場，特別是從製藥公司和醫療器材製造商等最終用戶的角度來看，正在經歷顯著的成長，因為這些行業正在探索先進的藥物輸送技術，以實現更有效和更有針對性的治療。這兩個行業都在擴大利用藥物整合聚合物纖維來改善患者治療效果並最佳化治療方案。

藥物整合聚合物纖維市場-地理洞察

北美引領市場擴張，主要受新興經濟體醫療保健支出不斷增加的推動。政府和私營部門對醫療基礎設施和醫學研究的資金增加促進了藥物整合聚合物纖維的進步和實施。根據美國醫學會報道，2022年美國醫療支出成長4.1%，達到4.5兆美元，相當於每人1,3493美元。這一成長率與疫情前的數據一致，具體為 2019 年的 4.1%。由於奈米技術和靜電紡絲技術的投資不斷增加，歐洲成為市場成長第二大地區。

藥物整合聚合物纖維市場-競爭格局：

藥物整合聚合物纖維市場競爭激烈，特色是眾多知名企業爭相透過創造創新產品和先進的藥物輸送系統來搶佔市場佔有率。由於對有針對性的藥物輸送機制、微創醫療設備和生物相容性材料的需求不斷成長，該市場正在經歷成長。該領域的公司致力於開發能夠持續釋放藥物同時確保藥物的生物相容性和功效的先進聚合物纖維。此外，這些公司正在與製藥組織、生技公司和學術機構建立合作關係，以加強其產品開發並獲得最先進的技術。

最新動態：

2024 年 6 月 25 日，包括藥膏和注射器在內的醫療產品在提供局部藥物傳輸方面遇到了挑戰，尤其是在長時間內以受控的方式輸送藥物。為了解決這個問題，Empa 的研究人員正在創新聚合物纖維，旨在長時間精確地輸送活性成分。這些液芯纖維封裝了藥物，可以整合到醫用紡織品中。

目錄

第 1 章：藥物整合聚合物纖維市場概述

  • 研究範圍
  • 市場估計年限

第 2 章：執行摘要

  • 市場片段
    • 藥物整合聚合物纖維市場按類型細分
    • 藥物整合聚合物纖維市場片段（按應用）
    • 藥物整合聚合物纖維市場片段（按治療適應症）
    • 藥物整合聚合物纖維市場片段（按最終用戶）
    • 藥物整合聚合物纖維市場（按國家/地區）摘要
    • 藥物整合聚合物纖維市場按地區細分
  • 競爭洞察

第 3 章：藥物整合聚合物纖維關鍵市場趨勢

  • 藥物整合聚合物纖維市場促進因素
    • 市場促進因素的影響分析
  • 藥物整合聚合物纖維市場限制
    • 市場限制的影響分析
  • 藥物整合聚合物纖維市場機會
  • 藥物整合聚合物纖維市場未來趨勢

第4章：藥物整合聚合物纖維產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景規劃
  • 規範架構分析

第5章：藥物整合聚合物纖維市場：地緣政治緊張局勢升級的影響

  • 新冠肺炎疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：藥物整合聚合物纖維市場格局

  • 藥物整合聚合物纖維市場佔有率分析，2024 年
  • 按主要製造商分類的細分數據
    • 成熟玩家分析
    • 新興企業分析

第 7 章：藥物整合聚合物纖維市場 - 按類型

  • 概述
    • 按類型分類的細分市場佔有率分析
    • 聚乳酸（PLA）
    • 聚二氧化酮 (PDO)
    • 聚己內酯（PCL）
    • 其他（PGA、PLGA 和 PDLL）

第 8 章：藥物整合聚合物纖維市場 - 按應用

  • 概述
    • 按應用細分市場佔有率分析
    • 藥物輸送
    • 骨科縫合線
    • 血管支架
    • 血管移植
    • 皮膚傷口癒合
    • 其他

第9章：藥物整合聚合物纖維市場 - 按治療適應症

  • 概述
    • 按治療適應症分類的細分市場佔有率分析
    • 癌症
    • 心血管疾病
    • 呼吸系統疾病

第 10 章：藥物整合聚合物纖維市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 製藥公司
    • 醫療器材製造商

第 11 章：藥物整合聚合物纖維市場-按地區

  • 介紹
    • 按地區分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美藥物整合聚合物纖維主要製造商
    • 北美市場規模及預測（按國家/地區）
    • 北美市場規模和預測（按類型）
    • 北美市場規模與預測，按應用分類
    • 北美市場規模及預測（依治療適應症分類）
    • 北美市場規模及預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲藥物整合聚合物纖維主要製造商
    • 歐洲市場規模及預測（按國家）
    • 歐洲市場規模與預測（按類型）
    • 歐洲市場規模和預測，按應用
    • 歐洲市場規模及預測（依治療適應症分類）
    • 歐洲市場規模及預測（按最終用戶）
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區藥物整合聚合物纖維主要製造商
    • 亞太地區市場規模及預測（依國家/地區分類）
    • 亞太地區市場規模及預測（按類型）
    • 亞太地區市場規模及預測（按應用分類）
    • 亞太地區市場規模及預測（依治療適應症分類）
    • 亞太地區市場規模及預測（依最終用戶）
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲 (LATAM)
    • 概述
    • 拉丁美洲藥物整合聚合物纖維主要製造商
    • 拉丁美洲市場規模及預測（按國家/地區）
    • 拉丁美洲市場規模及預測（按類型）
    • 拉丁美洲市場規模及預測（按應用分類）
    • 拉丁美洲市場規模及預測（依治療適應症分類）
    • 拉丁美洲市場規模及預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲 (MEA)
    • 概述
    • 中東和非洲藥物整合聚合物纖維主要製造商
    • MEA 市場規模及預測（依國家/地區分類）
    • MEA 市場規模和預測（按類型）
    • MEA 市場規模及預測（按應用）
    • MEA 市場規模及預測（依治療適應症分類）
    • MEA 市場規模及預測（依最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 其他地區

第 12 章：關鍵供應商分析-藥物整合聚合物纖維產業

  • 競爭儀錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司簡介
    • Asahi Kasei Corporation
    • Teijin Aramid
    • Toray Industries Inc.
    • Lycra (Invista)
    • Kaneka Corporation
    • Mitsubishi Chemical Corporation
    • Celanese Corporation
    • Teijin Limited
    • DuPont de
    • Nemours Inc.
    • Rhodia (Solvay)
    • Solvay SA
    • BASF SE
    • Sumitomo Chemical Company Limited
    • Evonik Industries AG
    • Kureha Corporation
    • Others

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4821

REPORT HIGHLIGHT

The Drug Integrated Polymer Fibers Market was valued at US$ 85.98 million in 2024 and expanded at a CAGR of 5.90% from 2025 to 2032.

Drug Integrated Polymer Fibers are advanced fibers composed of polymers that are infused with therapeutic agents to facilitate controlled and sustained drug release. These fibers are engineered to administer medications directly to targeted areas within the body or to distribute them throughout the system over an extended duration, thereby improving the efficacy and accuracy of medical treatments. Their applications are numerous, particularly within the medical and pharmaceutical sectors, where they serve purposes such as implantable drug delivery systems, wound management, and surgical sutures.

Drug Integrated Polymer Fibers Market- Market Dynamics

Rising Demand for Personalized Medicine is expected to the market growth.

Personalized medicine is revolutionizing drug delivery by facilitating targeted treatments that are specific to individual patients, which in turn is promoting the use of polymer-based drug delivery systems. Polymer fibers that incorporate drugs enable the controlled and sustained release of medications, thereby ensuring that therapeutic effects are optimized according to the unique needs of each patient. In 2023, the FDA approved 16 new personalized treatments aimed at patients with rare diseases, a significant increase from the six approvals in 2022. Among the newly approved treatments for 2023, there are seven drugs for cancer and three addressing other diseases and conditions, as reported by the Personalized Medicine Coalition. Nevertheless, advancements in fiber manufacturing technology may present growth opportunities for the market. Conversely, high manufacturing costs could impede market expansion.

Drug Integrated Polymer Fibers Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.90% over the forecast period (2025-2032)

Based on Type segmentation, Polylactic Acid (PLA) was predicted to show maximum market share in the year 2024

Based on application segmentation, Orthopedic Sutures was the leading application in 2024

Based on region, North America was the leading revenue generator in 2024

Drug Integrated Polymer Fibers Market- Segmentation Analysis:

The Global Drug Integrated Polymer Fibers Market is segmented based on Type, Application, Therapeutic Indication, End-User, and Region.

The market is divided into three categories based on Type: Polylactic Acid (PLA), Polydioxanone (PDO), Polycaprolactone (PCL), and Others (PGA, PLGA, and PDLL). Polylactic Acid (PLA) leads the market. Polylactic Acid (PLA), a biodegradable and biocompatible polymer, is frequently used in this market due to its ability to be processed into fibers, films, and other forms for controlled drug release. PLA is derived from renewable resources like cornstarch or sugarcane, making it an eco-friendly choice. Its biodegradability allows for the gradual breakdown of the fibers in the body, minimizing the need for surgical removal.

The market is divided into five categories based on application: Drug Delivery, Orthopedic Sutures, Vascular Stents, Vascular Grafts, Dermal Wound Healing, and Others. Orthopedic Sutures dominate the market. The Drug Integrated Polymer Fibers Market in the Context of Orthopedic Sutures represents a promising and rapidly evolving segment within the medical device industry, combining the biocompatibility of polymer fibers with the need for effective and localized drug delivery in orthopedic applications. Orthopedic sutures made from drug-integrated polymer fibers are designed to promote healing by delivering drugs directly to the surgical site. This is particularly important in orthopedic surgeries, where proper healing of bone and soft tissue is critical for long-term recovery.

The market is divided into three categories based on Therapeutic Indications: Cancer, Cardiovascular Diseases, and Respiratory Diseases. As technology advances, these fibers will become more sophisticated, allowing for better-controlled drug release and personalized treatment approaches, ultimately improving patient outcomes and quality of life. One of the most significant advantages of using polymer fibers for drug delivery in these therapeutic areas is the ability to provide localized and targeted treatment, minimizing systemic side effects. The development of drug-integrated polymer fibers must meet rigorous regulatory requirements, particularly regarding biocompatibility, safety, and long-term efficacy.

The market is divided into two categories based on End-User: Pharmaceutical Companies and Medical Device Manufacturers. The Drug Integrated Polymer Fibers Market, particularly from the perspective of end-users like Pharmaceutical Companies and Medical Device Manufacturers, is experiencing significant growth as these sectors explore advanced drug delivery technologies for more effective and targeted therapies. Both industries are increasingly leveraging drug-integrated polymer fibers to improve patient outcomes and optimize treatment regimens.

Drug Integrated Polymer Fibers Market- Geographical Insights

North America leads the market expansion, primarily driven by the increasing healthcare expenditures in emerging economies. The rise in funding from both government and private sectors for healthcare infrastructure and medical research facilitates the advancement and implementation of drug-integrated polymer fibers. As reported by the American Medical Association, health spending in the United States rose by 4.1% in 2022, reaching USD 4.5 trillion, which translates to USD 13,493 per capita. This growth rate aligns with pre-pandemic figures, specifically 4.1% in 2019. While government expenditures aimed at managing the pandemic resulted in significant increases in National Health Expenditure (NHE), these costs saw a notable decline in 2021, coinciding with a resurgence in the utilization of medical goods and services. Europe ranks as the second-largest region for market growth, attributed to the increasing investments in nanotechnology and electrospinning techniques.

Drug Integrated Polymer Fibers Market- Competitive Landscape:

The Drug Integrated Polymer Fibers Market exhibits a high level of competition, characterized by numerous prominent entities striving to capture market share through the creation of innovative products and sophisticated drug delivery systems. This market is experiencing growth driven by the rising demand for targeted drug delivery mechanisms, minimally invasive medical devices, and biocompatible materials. Firms operating in this sector are dedicated to the development of advanced polymer fibers capable of providing sustained drug release while ensuring the biocompatibility and efficacy of pharmaceuticals. Additionally, these companies are establishing collaborations with pharmaceutical organizations, biotechnology firms, and academic institutions to bolster their product development efforts and gain access to state-of-the-art technologies.

Recent Developments:

On June 25, 2024, Medical products, including ointments and syringes, encountered challenges in providing localized medication delivery, particularly in a controlled manner over extended durations. In response to this issue, researchers at Empa are innovating polymer fibers designed to deliver active ingredients with precision over prolonged periods. These liquid core fibers encapsulate pharmaceuticals and can be integrated into medical textiles.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DRUG INTEGRATED POLYMER FIBERS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Asahi Kasei Corporation
  • Teijin Aramid
  • Toray Industries Inc.
  • Lycra (Invista)
  • Kaneka Corporation
  • Mitsubishi Chemical Corporation
  • Celanese Corporation
  • Teijin Limited
  • DuPont de
  • Nemours Inc.
  • Rhodia (Solvay)
  • Solvay S.A.
  • BASF SE
  • Sumitomo Chemical Company Limited
  • Evonik Industries AG
  • Kureha Corporation
  • Others

GLOBAL DRUG INTEGRATED POLYMER FIBERS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Polylactic Acid (PLA)
  • Polydioxanone (PDO)
  • Polycaprolactone (PCL)
  • Others (PGA, PLGA and PDLL)

GLOBAL DRUG INTEGRATED POLYMER FIBERS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Drug Delivery
  • Orthopedic Sutures
  • Vascular Stents
  • Vascular Grafts
  • Dermal Wound Healing
  • Others

GLOBAL DRUG INTEGRATED POLYMER FIBERS MARKET, BY THERAPEUTIC INDICATION- MARKET ANALYSIS, 2019 - 2032

  • Cancer
  • Cardiovascular Diseases
  • Respiratory Diseases

GLOBAL DRUG INTEGRATED POLYMER FIBERS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical Companies
  • Medical Device Manufacturers

GLOBAL DRUG INTEGRATED POLYMER FIBERS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Drug Integrated Polymer Fibers Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Drug Integrated Polymer Fibers Market Snippet by Type
    • 2.1.2. Drug Integrated Polymer Fibers Market Snippet by Application
    • 2.1.3. Drug Integrated Polymer Fibers Market Snippet by Therapeutic Indication
    • 2.1.4. Drug Integrated Polymer Fibers Market Snippet by End-User
    • 2.1.5. Drug Integrated Polymer Fibers Market Snippet by Country
    • 2.1.6. Drug Integrated Polymer Fibers Market Snippet by Region
  • 2.2. Competitive Insights

3. Drug Integrated Polymer Fibers Key Market Trends

  • 3.1. Drug Integrated Polymer Fibers Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Drug Integrated Polymer Fibers Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Drug Integrated Polymer Fibers Market Opportunities
  • 3.4. Drug Integrated Polymer Fibers Market Future Trends

4. Drug Integrated Polymer Fibers Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Drug Integrated Polymer Fibers Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Drug Integrated Polymer Fibers Market Landscape

  • 6.1. Drug Integrated Polymer Fibers Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Drug Integrated Polymer Fibers Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
    • 7.1.2. Polylactic Acid (PLA)
    • 7.1.3. Polydioxanone (PDO)
    • 7.1.4. Polycaprolactone (PCL)
    • 7.1.5. Others (PGA, PLGA and PDLL)

8. Drug Integrated Polymer Fibers Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Drug Delivery
    • 8.1.3. Orthopedic Sutures
    • 8.1.4. Vascular Stents
    • 8.1.5. Vascular Grafts
    • 8.1.6. Dermal Wound Healing
    • 8.1.7. Others

9. Drug Integrated Polymer Fibers Market - By Therapeutic Indication

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Therapeutic Indication, 2024 & 2032 (%)
    • 9.1.2. Cancer
    • 9.1.3. Cardiovascular Diseases
    • 9.1.4. Respiratory Diseases

10. Drug Integrated Polymer Fibers Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
    • 10.1.2. Pharmaceutical Companies
    • 10.1.3. Medical Device Manufacturers

11. Drug Integrated Polymer Fibers Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Drug Integrated Polymer Fibers Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Drug Integrated Polymer Fibers Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Drug Integrated Polymer Fibers Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Drug Integrated Polymer Fibers Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Drug Integrated Polymer Fibers Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Therapeutic Indication, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Drug Integrated Polymer Fibers Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Asahi Kasei Corporation
    • 12.2.2. Teijin Aramid
    • 12.2.3. Toray Industries Inc.
    • 12.2.4. Lycra (Invista)
    • 12.2.5. Kaneka Corporation
    • 12.2.6. Mitsubishi Chemical Corporation
    • 12.2.7. Celanese Corporation
    • 12.2.8. Teijin Limited
    • 12.2.9. DuPont de
    • 12.2.10. Nemours Inc.
    • 12.2.11. Rhodia (Solvay)
    • 12.2.12. Solvay S.A.
    • 12.2.13. BASF SE
    • 12.2.14. Sumitomo Chemical Company Limited
    • 12.2.15. Evonik Industries AG
    • 12.2.16. Kureha Corporation
    • 12.2.17. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us